Thursday, November 5, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

UNLV doctor talks peptide safety, risk after new FDA policy revealed

LAS VEGAS — The Trump administration acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. and a UNLV doctor is detailing the safety and…

DO
By Daniel Okafor · Regulatory Correspondent
Nov 5 12:02 ETSource: KSNV

From the source

UNLV doctor talks peptide safety, risk after new FDA policy revealed

LAS VEGAS — The Trump administration acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. and a UNLV doctor is detailing the safety and risks.

Read at news3lv.com
PeptiPrescribed peptides from $99/moSee all →